LIVER CANCER
Clinical trials for LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new LIVER CANCER trials appear
Sign up with your email to follow new studies for LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat gut cancers: first human trial launched
Disease control CompletedThis early study tested a new drug called Cabotamig (ARB202) in 33 adults with advanced gastrointestinal cancers (like stomach, liver, or bowel cancer) that had stopped responding to standard treatments. The drug works by targeting a marker called CDH17 on cancer cells and helpin…
Matched conditions: LIVER CANCER
Phase: PHASE1 • Sponsor: Arbele Pty Ltd • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
Precision proton beam shows promise against inoperable liver tumors
Disease control CompletedThis study looked at whether a precise type of radiation called proton beam therapy can control liver cancer that cannot be surgically removed. It included 83 adults with liver cancer. The goal was to see if this treatment can kill cancer cells while causing fewer side effects th…
Matched conditions: LIVER CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 03:05 UTC
-
New combo therapy shows promise for inoperable liver cancer
Disease control CompletedThis study tested a new combination treatment for people with liver cancer that cannot be removed by surgery. The treatment included chemotherapy delivered directly to the liver, a procedure to block the tumor's blood supply, and two drugs (lenvatinib and tislelizumab). The goal …
Matched conditions: LIVER CANCER
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
New drug combo shows promise against tough cancers in early trial
Disease control CompletedThis early-stage study tested a new drug (BI 765049) alone or with another drug (ezabenlimab) in 21 Asian adults with advanced cancers like stomach, lung, or liver cancer that had stopped responding to treatment. The goal was to find a safe dose and see if the drugs could shrink …
Matched conditions: LIVER CANCER
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
Yeast vaccine trains immune system to fight returning cancers
Disease control CompletedThis early-phase study tested a personalized vaccine made from yeast that is designed to teach the immune system to recognize and attack leftover cancer cells. It included 5 adults with different cancers who had already completed treatment aimed at curing their disease. The goal …
Matched conditions: LIVER CANCER
Phase: PHASE1 • Sponsor: NantBioScience, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Targeted chemo for inoperable liver cancer shows promise in trial
Disease control CompletedThis study tested two chemotherapy drugs, cisplatin and mitomycin-C, given directly into the liver artery for people with liver cancer that cannot be surgically removed. The goal was to see how long it takes for tumors to grow and to monitor side effects. The study also looked at…
Matched conditions: LIVER CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New ultrasound technique may spare patients unnecessary liver biopsies
Diagnosis CompletedThis study tested whether a special type of ultrasound with contrast dye (CEUS) can more accurately identify liver lesions found on regular ultrasound. Researchers compared CEUS to CT, MRI, and biopsy in 878 adults with liver spots. The goal was to see if CEUS could provide a rel…
Matched conditions: LIVER CANCER
Phase: NA • Sponsor: University Hospital, Tours • Aim: Diagnosis
Last updated May 26, 2026 03:10 UTC
-
Quick MRI outshines ultrasound for liver cancer detection in cirrhosis patients
Diagnosis CompletedThis study tested whether a shorter, contrast-enhanced MRI (called AMRI) works better than standard ultrasound for finding liver cancer early in people with liver cirrhosis. Researchers enrolled 79 adults with cirrhosis and compared the accuracy of both imaging methods. The goal …
Matched conditions: LIVER CANCER
Phase: PHASE4 • Sponsor: University of California, San Diego • Aim: Diagnosis
Last updated May 26, 2026 03:06 UTC
-
New blood markers could spot liver cancer sooner
Diagnosis CompletedThis study looked for new substances in the blood that could help diagnose liver cancer more accurately. Researchers tested blood samples from 573 people, including those with liver cancer, other liver diseases, and hepatitis infections. The goal is to improve upon current tests …
Matched conditions: LIVER CANCER
Sponsor: Stanford University • Aim: Diagnosis
Last updated May 15, 2026 11:56 UTC
-
Could a common numbing drug cut opioid use after liver surgery?
Symptom relief CompletedThis study tested whether giving lidocaine through a vein during liver surgery can reduce pain and the need for strong painkillers afterward. 124 adults having minor liver surgery were randomly assigned to receive either lidocaine or a placebo (salt water). The main goal was to s…
Matched conditions: LIVER CANCER
Phase: PHASE2, PHASE3 • Sponsor: Lund University Hospital • Aim: Symptom relief
Last updated May 26, 2026 03:08 UTC
-
French liver cancer Patients' data collected to assess SIR-Spheres reimbursement
Knowledge-focused CompletedThis study is a registry that collected information from 332 liver cancer patients in France who were treated with SIR-Spheres, a type of internal radiation therapy. The goal was to describe how the treatment is used in real life and to report safety and effectiveness data to hea…
Matched conditions: LIVER CANCER
Sponsor: Cardiovascular and Interventional Radiological Society of Europe • Aim: Knowledge-focused
Last updated May 26, 2026 03:19 UTC
-
AI predicts liver cancer spread: men vs. women risks revealed
Knowledge-focused CompletedThis study analyzed data from over 19,000 liver cancer patients to see if the risk of cancer spreading (metastasis) differs between men and women. Researchers used machine learning to create separate prediction models for each sex. The goal was to improve early detection and pers…
Matched conditions: LIVER CANCER
Sponsor: Tongji University • Aim: Knowledge-focused
Last updated May 26, 2026 03:05 UTC
-
Blood marker trends may sharpen liver cancer prognosis
Knowledge-focused CompletedThis study looked at 379 people with liver cancer to see if monitoring changes in blood markers over time, along with standard clinical information, could better predict how the disease will progress. The goal was to create a more accurate tool for doctors to personalize treatmen…
Matched conditions: LIVER CANCER
Sponsor: Xu Yong, MD • Aim: Knowledge-focused
Last updated May 26, 2026 03:05 UTC
-
Microscope or loupes? study tests best tool for liver transplant bile duct repair
Knowledge-focused CompletedThis study looked at 52 adults who had a living-donor liver transplant to see if using a microscope or surgical loupes (magnifying glasses) leads to fewer bile duct problems after surgery. The goal was to find out which tool helps reduce complications like leaks or narrowing of t…
Matched conditions: LIVER CANCER
Phase: NA • Sponsor: Istanbul Medipol University Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 02:48 UTC
-
Breath test could spot liver cancer and COVID-19
Knowledge-focused CompletedThis study tested whether a breath analysis test could help diagnose or predict the course of liver diseases, liver cancer, and COVID-19. Researchers collected breath samples from 46 participants to detect unique chemical patterns. The goal was to develop a non-invasive diagnosti…
Matched conditions: LIVER CANCER
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC
-
New registry aims to gather data on rare liver cancer
Knowledge-focused CompletedThis study created a worldwide registry for people with fibrolamellar cancer (FLC), a rare liver cancer. Researchers collected information from 12 participants about their medical history and routine care. The goal was to build a database that can be used for future studies. No t…
Matched conditions: LIVER CANCER
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 18, 2026 12:13 UTC
-
New scanner aims to sharpen cancer radiation images
Knowledge-focused CompletedThis study tested a new type of CT scanner that takes pictures during radiation therapy for lung, liver, breast, and other cancers. The goal was to see if the new scanner produces clearer images with fewer distortions. 31 people participated, and the results will help doctors bet…
Matched conditions: LIVER CANCER
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Knowledge-focused
Last updated May 18, 2026 12:08 UTC